- Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectivenessRodrigo Refoios Camejo
HTA Policy International Affairs, Pfizer Inc, Surrey, United Kingdom
Value Health 15:381-8. 2012..The objective of this study is to provide an empirical basis for this discussion by estimating the potential for price decreases to impact on the cost-effectiveness of new therapies in hypertension...
- A dynamic perspective on pharmaceutical competition, drug development and cost effectivenessRodrigo Refoios Camejo
Pfizer Inc, Surrey, UK
Health Policy 100:18-24. 2011..We conclude that disease-specific characteristics are an additional consideration in CE decision rules to accommodate the particularities of innovation across disease areas...